Phase II Trial: The Combination of Tacrolimus, Sirolimus, and Rabbit Anti-Thymocyte Globulin (Thymoglobulin® Thymo) to Prevent Acute Graft-vs.-Host Disease (aGVHD) in Patients Receiving Unrelated Hematopoietic Stem Cell Transplantation (UHSCT)

✍ Scribed by Z. Al-Kadhimi; Z. Gul; R. Rodriguez; W. Chen; A. Mitchell; M. Abidi; L. Ayash; A. Deol; L. Lum; V. Ratanatharathorn; J. Uberti

• Book ID: 116282353
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 56 KB
• Volume: 17
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2010.12.417